Phase II trial of karenitecin (BNP1350) in malignant: Clinical and translational study

7554 Background: To determine the efficacy and safety of the novel camptothecin, karenitecin (BNP1350), in patients with metastatic melanoma and to measure the level of expression of topoisomerase ...